
Ipsen Reports €7.33 Non-GAAP EPS, €2.19 Billion Revenue; Upgrades 2026 Guidance
Ipsen S.A. announced non-GAAP earnings per share of €7.33 and revenue of €2.19 billion. The pharmaceutical company also upgraded its financial guidance for fiscal year 2026.



















